About Kerry Love
Form D filings for Sunflower Therapeutics, PBC from 2022 to 2024 list Kerry Love as chief executive officer and director.
Kerry Love first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Kerry Love in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kerry Love works with at each company, as listed on that company's latest Form D.
Sunflower Therapeutics, PBC · Form D, May 24, 2024